TOP 10 Countries by Health Expenditure per Capita (2025)
Why this version uses PPP instead of mixing apples and oranges
Health expenditure per capita is one of the clearest ways to compare how many financial resources a country channels into care for each resident. But a serious cross-country article cannot jump back and forth between current US dollars and PPP-adjusted international dollars as if they were interchangeable. Current-dollar rankings are useful for nominal budget scale, while PPP-adjusted figures are better for structural comparison because they reduce exchange-rate noise.
For that reason, this rewrite uses a single consistent metric throughout: total health expenditure per capita in PPP international dollars, 2024 or nearest year, presented as a practical 2025 outlook. It is a cleaner basis for ranking high-spending systems than the mixed approach in the source draft.
Top 10 countries by health expenditure per capita
The United States remains the clear outlier. It spends vastly more per person than any peer, yet that spending is routed through a fragmented mix of public programmes, employer insurance, private plans and household payments. The country leads on resource intensity, not necessarily on efficiency or financial protection.
Switzerland combines very high spending with universal mandatory coverage through regulated insurers. It offers strong access and high-quality care, but deductibles and premiums mean households still feel costs more directly than in many tax-funded systems.
Norway’s position reflects both high national income and a tax-funded model with broad public coverage. Per-capita spending is high, but the financing structure is much more pooled and protective than in the United States.
Germany belongs in the top tier in the latest comparable dataset and should not be missing from a serious 2025-style overview. Its social insurance model supports dense provider capacity, generous coverage and high health-system throughput.
The Dutch system pairs universal mandatory insurance with managed competition. Spending is high, but the model is often cited for balancing access, insurer regulation and relatively disciplined system design.
Austria’s high rank reflects a mature social health insurance architecture, dense hospital provision and strong public financing. It is a reminder that high-spending systems are not only Anglo-Saxon or Nordic.
Luxembourg combines very high income with a small population and generous social protection. As with many small affluent states, per-capita figures are supported by a compact tax base and strong wage levels.
Sweden’s tax-funded model shows that high spending can coexist with broad pooling and relatively low direct household exposure. The core policy debate is less about access than about staffing, waiting times and ageing.
Ireland sits among the top spenders despite a system that still mixes public entitlements and private insurance. High spending has not fully eliminated bottlenecks, which makes it a useful case in the spending-versus-delivery debate.
Belgium rounds out the top 10 with a social insurance model that offers wide provider choice and strong protection. It is another example of a country where high spending is embedded in long-standing institutional coverage.
Methodology
This version ranks countries using health expenditure per capita in PPP international dollars, not current-dollar figures. That choice is deliberate. PPP-adjusted values are more appropriate when the goal is to compare health-system resource intensity across countries rather than nominal budget size at market exchange rates.
The reference year is 2024 or nearest year, used here as a 2025 outlook. OECD Health Statistics 2025 provides the latest comparable values for OECD members and selected partner countries, while WHO’s Global Health Expenditure Database and the World Bank indicator pages provide the broader definitional base and country reporting framework.
The main limitations are straightforward. First, 2024 values can be provisional or estimated in some datasets. Second, even PPP figures do not tell you whether money is spent efficiently. Third, small institutional differences matter: some systems push costs through public budgets, others through compulsory insurance, voluntary insurance or household out-of-pocket payments. A ranking of spending is therefore not a ranking of outcomes.
Key insights
The most important pattern is concentration. Very high health spending per person remains a feature of a relatively small club of rich countries. Once you move below the top tier, the drop is steep. The United States is not just first; it is in a league of its own.
The second pattern is institutional diversity inside the high-spending club. The top 10 includes tax-funded systems, classic social insurance systems and regulated private-insurance models. That matters because similar spending levels can produce very different experiences for households depending on deductibles, waiting times, provider access and the size of the out-of-pocket burden.
The third pattern is that spending and outcomes do not move one-to-one. Rich countries with universal pooling often translate high expenditure into stronger financial protection, while fragmented systems can spend even more but still leave patients exposed to cost barriers. In other words, the financing architecture is as important as the spending total.
What this means for the reader
For readers comparing countries as places to live, work or retire, this ranking is useful as a signal of system capacity, not as a final verdict on care quality. A country that spends a lot usually has more staff, technology and treatment capacity available than a lower-spending system, but that does not automatically mean easier access or lower household stress.
For personal finance, the question is not only “how much does the country spend?” but also “how much of that cost is socialised, and how much lands on the household?” Two countries can sit near each other in the ranking while offering very different real-world protection against medical bills.
For investors and employers, high spending often signals a large and sophisticated health economy: hospitals, pharmaceuticals, diagnostics, insurance, medtech and elder-care services. But it can also signal fiscal pressure, especially in ageing societies where labour shortages and chronic disease push system costs upward year after year.
FAQ
Why did you switch from current US dollars to PPP?
Because a 2025 comparison should use one metric consistently. Current US dollars are heavily influenced by exchange rates, while PPP better reflects the relative volume of health resources each country commands domestically.
Does the United States spend the most because Americans use more care?
Not only. The US spends more partly because prices are higher across hospitals, physicians, pharmaceuticals and administration. Volume matters, but price and system structure matter even more.
Does a higher rank mean better healthcare outcomes?
No. It means a country devotes more spending per person to health. Outcomes depend on prevention, equity, access, primary care strength, population behaviour, prices and how efficiently the system is run.
Why is Germany in the top group here when it was missing in the draft?
Because the draft leaned on an older and mixed presentation. In the latest comparable OECD-style PPP dataset, Germany clearly belongs among the highest spenders.
Can a country spend less and still protect households better?
Yes. A country with strong pooled financing and lower out-of-pocket exposure can feel safer for residents than a richer country that spends more overall but leaves households with higher direct bills.
Table and chart: how large the top-tier spending gap really is
The ranking below keeps the same unit all the way through: PPP-adjusted health expenditure per capita. That makes the comparison cleaner than a mixed current-dollar article, especially when benchmarking the United States against European systems.
Top 10 table
| Rank | Country | Spending per capita | System profile |
|---|---|---|---|
| 1 | United States | 14,885 PPP $ | Mixed public-private model with unusually high prices and fragmented financing. |
| 2 | Switzerland | 9,963 PPP $ | Mandatory private insurance with strong regulation and broad coverage. |
| 3 | Norway | 9,393 PPP $ | Tax-funded universal model with high pooling and strong public role. |
| 4 | Germany | 9,365 PPP $ | Social insurance system with high provider capacity and broad benefits. |
| 5 | Netherlands | 8,436 PPP $ | Managed-competition insurance model with universal mandatory package. |
| 6 | Austria | 8,401 PPP $ | Social insurance with strong public financing and dense service provision. |
| 7 | Luxembourg | 8,162 PPP $ | Small affluent social insurance system with generous protection. |
| 8 | Sweden | 7,871 PPP $ | Tax-funded universal model with relatively low direct household exposure. |
| 9 | Ireland | 7,813 PPP $ | High-spending mixed model with both public entitlements and private cover. |
| 10 | Belgium | 7,750 PPP $ | Social insurance with wide provider choice and strong reimbursement rules. |
Source base: OECD Health Statistics 2025, 2024 or nearest year. This table is intentionally kept in one comparable unit.
Bar chart: top 10 versus the OECD average
United States 14,885; Switzerland 9,963; Norway 9,393; Germany 9,365; Netherlands 8,436; Austria 8,401; Luxembourg 8,162; Sweden 7,871; Ireland 7,813; Belgium 7,750; OECD average ≈ 6,000.
The gap is the story. The United States is not marginally above peers; it is dramatically above them. The rest of the top 10 cluster in a much narrower high-spending band, broadly between 7,750 and 10,000 PPP dollars per person.
How to read the chart correctly
First, the United States should be interpreted as an outlier rather than a normal benchmark. A country sitting closer to 8,000 or 9,000 PPP dollars is still an extremely high spender by international standards.
Second, once countries are inside the rich-country tier, the policy question shifts from “can we spend more?” to “how do we organise what we already spend?” Systems with similar spending levels can differ sharply in access, waiting times and household burden.
Third, the OECD average matters because it shows the baseline of affluent-country spending. The whole top 10 sits clearly above that benchmark, but not all of them sit equally far above it.
Interpretation: what the ranking does and does not prove
A top-spending country is not automatically a top-performing country. High per-capita expenditure tells us that a system mobilises large resources, but it does not by itself tell us whether those resources are allocated efficiently, whether waiting times are reasonable, or whether households are shielded from financial strain.
The strongest contrast is between resource intensity and financial protection. The United States dominates the ranking, but that does not make it the easiest system for patients to navigate. By contrast, several Western and Northern European countries spend somewhat less while pooling a larger share of costs through taxes or compulsory social insurance.
That is why serious readers should pair this ranking with at least three companion indicators: life expectancy or avoidable mortality, out-of-pocket share of total health expenditure, and waiting-time or access indicators. Spending is essential, but it is not the whole health-system story.
Policy takeaways
1. Prices matter as much as volumes. Countries can reach similar spending totals for completely different reasons. In some systems, spending is driven by high wages, provider prices and pharmaceutical costs. In others, it reflects denser public capacity and broader universal entitlement.
2. Pooling matters for household security. Two countries may both spend heavily, but one may finance most care collectively while the other leaves a larger burden on patients through premiums, deductibles or direct payments.
3. Ageing will keep pressure on the rich-country tier. The top of the table is dominated by ageing societies with advanced medicine, expensive labour and rising long-term care needs. That means the real policy debate is no longer whether health spending will grow, but how to fund that growth without sacrificing access or fiscal stability.
4. Rankings should be read as diagnostics, not trophies. A spending table is most useful when it leads to better questions about efficiency, prevention, access, labour shortages and patient protection.
Official sources
- OECD — Health expenditure per capita, Health at a Glance 2025 https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/health-expenditure-per-capita_affe6b0a.html
- World Bank — Current health expenditure per capita (current US$) https://data.worldbank.org/indicator/SH.XPD.CHEX.PC.CD
- WHO — Global Health Expenditure Database https://apps.who.int/nha/database
- WHO — Indicator definition: Current health expenditure per capita in US$ https://www.who.int/data/gho/data/indicators/indicator-details/GHO/current-health-expenditure-%28che%29-per-capita-in-us-dollar
